The National Association of Boards of Pharmacy (NABP) just announced pricing changes effective December 18, 2024, for their Drug Distributor Accreditation program.
NABP’s Drug Distributor Accreditation plays a role in preventing counterfeit drugs and devices from entering the United States medical supply. It’s also required in certain states to complete this accreditation to obtain state licensing.
The NABP Drug Distributor Accreditation (NABP DDA fka VAWD) program consists of two phases. First, the Supply Chain Inspection (SCI), followed by the Accreditation (DDA) phase.
These are two separate applications and fees.
The old pricing will remain in effect until 6:00 pm CST on December 18, 2024.
Pricing for Phase 1, the Supply Chain Inspection (SCI), has increased $900. Here is the breakdown of pricing changes:
Pricing for Phase 2, the Drug Distributor Accreditation (DDA), has increased $1,220. Here is the breakdown of pricing changes:
The fees outlined above are just for the first year of the accreditation. The NABP DDA is a 3-year accreditation and there are additional fees that are paid for the 2nd and 3rd year. Those prices have changed as well.
With these new pricing changes that go into effect as of December 18th, 2024, a NABP Drug Distributor Accreditation will cost you $1,000 more. An increase from $11,500 to $12,500 for the entire process.
LighthouseAI offers professional assistance in preparing for and meeting all requirements related to the NABP DDA. If you would like help from one of our drug distributor accreditation experts, please complete our Contact Us form.